跳至主要内容
临床试验/CTRI/2021/03/032332
CTRI/2021/03/032332尚未招募3 期

Role of Faecal Microbiota Transplantation (FMT) in Inflammatory Bowel Disease

Dayanand Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age >15 years
  • Confirmed Ulcerative Colitis patients who are in clinical remission achieved either with FMT or with pharmacotherapy.
  • Patients must be on stable medication regimen for at least 6 months prior to enrollment.
  • Able to give informed consent and/or assent as appropriate

排除标准

  • Active disease, endoscopic Mayo score > 1, use of rectal therapies, evidence of active infection (stool positivefor Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacteror E. coli), use of probiotics or antibiotics within four weeks of enrollment, significant cardiopulmonary co-morbidities, changes in dosage or addition of new pharmacotherapy in last 6 months, severe immunodeficiency, pregnancy, lactation and unwillingness to undergo repeated colonoscopies.

研究者

发起方
Dayanand Medical College and Hospital

相似试验

Fecal Therapy for Colitis | 临床试验